81 related articles for article (PubMed ID: 15756443)
1. Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients.
Porta C; Imarisio I; De Amici M; Bonomi L; Paglino C; Biscaldi E; Zimatore M; Sartore-Bianchi A; Danova M; Moratti R; Riccardi A
Oncol Rep; 2005 Apr; 13(4):689-95. PubMed ID: 15756443
[TBL] [Abstract][Full Text] [Related]
2. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and basic fibroblast growth factor in patients with squamous cell oesophageal cancer.
Wallner G; Ciechański A; Dabrowski A; Kozłowski M; Roliński J; Laudański J; Cwik G
Folia Histochem Cytobiol; 2001; 39 Suppl 2():122-3. PubMed ID: 11820569
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
Granato AM; Nanni O; Falcini F; Folli S; Mosconi G; De Paola F; Medri L; Amadori D; Volpi A
Breast Cancer Res; 2004; 6(1):R38-45. PubMed ID: 14680499
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
6. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
[TBL] [Abstract][Full Text] [Related]
7. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms.
Sasaki H; Yukiue H; Kobayashi Y; Nakashima Y; Moriyama S; Kaji M; Kiriyama M; Fukai I; Yamakawa Y; Fujii Y
Surg Today; 2001; 31(11):1038-40. PubMed ID: 11766079
[TBL] [Abstract][Full Text] [Related]
10. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
[TBL] [Abstract][Full Text] [Related]
11. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
Waltham M; Burnand KG; Collins M; Smith A
J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
15. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of ampelopsin on angiogenesis].
Luo GQ; Zeng S; Liu DY
Zhong Yao Cai; 2006 Feb; 29(2):146-50. PubMed ID: 16617784
[TBL] [Abstract][Full Text] [Related]
17. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]